Known Medicine combines patient-specific 3D cell culture & AI to translate drugs to clinical success. We receive patient tumors, break them down, make thousands of micro-tumors, and then treat each with different drugs to determine which they will respond best to.
Research in tissue engineering, tumor microenvironments, cancer precision medicine. CEO at Known Medicine (S20) which raised ~$8.2M and was ultimately acquired by Pathos AI in spring 2023.
- Led a team of PhD Data Scientists at Recursion Pharma (AI for drug discovery) - Stanford BS in Computer Science - Stanford MS in Biomedical Informatics